BioSpace News Archive

The company, with sites in Seattle and South San Francisco, focuses on next-generation oncology therapeutics. It recently completed a portfolio review and decided to focus its energies and existing capital on G100 and abandoned its CMB305 program.

Every year, the Breakthrough Prize Foundation awards a collective total of $22 million to nine researchers for achievements in the Life Sciences, Fundamental Physics and Mathematics.

Multiple biotech companies are scheduled to release their quarterly reports next week. BioSpace takes a quick look at some these companies and the announcements they have made through 3Q2018.

MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four serotypes of Dengue Viruses; providing a new avenue for dengue prevention and/or treatment

Tactiva Therapeutics, a development stage company targeting a broad range of cancers, announced today that its co-founder Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, is among the 75 newly elected regular members of the National Academy of Medicine (NAM)

Jerry Lewis MD, announced today that the cellulite treatment Cellfina is now available at NOVO Med Spa. Cellfina is the only FDA-cleared, minimally invasive procedure clinically proven to treat the primary structural cause of cellulite for at least three years.

Aurora’s shares will trade on the NYSE under ticker symbol “ACB”, the same symbol the Company’s common shares currently, and will continue to, trade under on the Toronto Stock Exchange

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, andMorphic Therapeutic, a biotechnology company developing oral integrin therapies, announced today that the companies have entered into a research and development collaboration designed to advance a number of Morphic’s oral integrin therapeutics for fibrosis-related indications.

BulletinHealthcare, a leading provider of news briefings for top medical associations, today announced that it has launched its latest briefing to members of the American Society of Echocardiography (ASE).

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Glen Moller has joined the Company’s Board of Directors.